|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 18 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
D |
$94.53 |
$2,660,358 |
D/D |
(28,143) |
300,558 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-22 |
4 |
D |
$88.05 |
$1,155,832 |
D/D |
(13,127) |
323,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-03-13 |
4 |
D |
$84.50 |
$2,615,444 |
D/D |
(30,952) |
265,491 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-03-20 |
4 |
D |
$73.05 |
$959,000 |
D/D |
(13,128) |
297,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-15 |
4 |
D |
$78.39 |
$1,836,364 |
D/D |
(23,426) |
313,576 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-16 |
4 |
D |
$77.21 |
$429,210 |
D/D |
(5,559) |
308,017 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-22 |
4 |
D |
$78.52 |
$433,352 |
D/D |
(5,519) |
302,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-15 |
4 |
D |
$78.27 |
$2,998,211 |
D/D |
(38,306) |
340,543 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-16 |
4 |
D |
$80.72 |
$448,803 |
D/D |
(5,560) |
334,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-15 |
4 |
D |
$87.74 |
$828,002 |
D/D |
(9,437) |
514,519 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-16 |
4 |
D |
$93.41 |
$8,278,274 |
D/D |
(88,623) |
425,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-12 |
4 |
D |
$93.93 |
$3,755,415 |
D/D |
(39,981) |
432,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-03-15 |
4 |
D |
$83.87 |
$7,146,479 |
D/D |
(85,209) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
|
2012-10-23 |
5 |
GA |
$0.00 |
$0 |
I/I |
13,545 |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,064 |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,131 |
40,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-29 |
5 |
GA |
$0.00 |
$0 |
D/D |
7,011 |
233,168 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
200 |
100 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
|
2012-10-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
13,545 |
135,901 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
111,838 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,064 |
90,101 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,131 |
115,770 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
226,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
7,011 |
36,184 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
230,768 |
0 |
- |
|
850 Records found
|
|
Page 18 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|